Email updates

Keep up to date with the latest news and content from Genome Medicine and BioMed Central.

Journal App

google play app store
Open Access Correction

Correction: Gene expression and network-based analysis reveals a novel role for hsa-miR-9 and drug control over the p38 network in glioblastoma multiforme progression

Rotem Ben-Hamo and Sol Efroni*

Author Affiliations

The Mina and Everard Goodman Faculty of Life Science, Bar Ilan University, 1 Keren-Hayesod St, Ramat-Gan, 52900, Israel

For all author emails, please log on.

Genome Medicine 2012, 4:87  doi:10.1186/gm388


The electronic version of this article is the complete one and can be found online at: http://genomemedicine.com/2012/4/11/87


Received:15 November 2012
Accepted:20 November 2012
Published:29 November 2012

© 2012 BioMed Central Ltd.

Correction

It has come to our attention that there is an error in the Acknowledgements section of our article [1]. The Acknowledgements section should read:

SE is supported by the European Union through the IRG program. The results published here are in whole or part based upon data generated by The Cancer Genome Atlas pilot project established by the NCI and NHGRI. Information about TCGA and the investigators and institutions who constitute the TCGA research network can be found at the project website [2]

References

  1. Ben-Hamo R, Efroni S: Gene expression and network-based analysis reveals a novel role for hsa-miR-9 and drug control over the p38 network in glioblastoma multiforme progression.

    Genome Medicine 2011, 3:77. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text OpenURL

  2. The Cancer Genome Atlas. [http://cancergenome.nih.gov/] webcite

Have something to say? Post a comment on this article!